Exploring Water, Sanitation, and Hygiene Coverage Targets for Reaching and Sustaining Trachoma Elimination: G-computation Analysis
Overview
Tropical Medicine
Authors
Affiliations
Background: Trachoma is the leading infectious cause of blindness. To reduce transmission, water, sanitation, and hygiene (WaSH) improvements are promoted through a comprehensive public health strategy. Evidence supporting the role of WaSH in trachoma elimination is mixed and it remains unknown what WaSH coverages are needed to effectively reduce transmission.
Methods/findings: We used g-computation to estimate the impact on the prevalence of trachomatous inflammation-follicular among children aged 1-9 years (TF1-9) when hypothetical WaSH interventions raised the minimum coverages from 5% to 100% for "nearby" face-washing water (<30 minutes roundtrip collection time) and adult latrine use in an evaluation unit (EU). For each scenario, we estimated the generalized prevalence difference as the TF1-9 prevalence under the intervention scenarios minus the observed prevalence. Data from 574 cross-sectional surveys conducted in 16 African and Eastern Mediterranean countries were included. Surveys were conducted from 2015-2019 with support from the Global Trachoma Mapping Project and Tropical Data. When modeling interventions among EUs that had not yet met the TF1-9 elimination target, increasing nearby face-washing water and latrine use coverages above 30% was generally associated with consistent decreases in TF1-9. For nearby face-washing water, we estimated a ≥25% decrease in TF1-9 at 65% coverage, with a plateau upon reaching 85% coverage. For latrine use, the estimated decrease in TF1-9 accelerated from 80% coverage upward, with a ≥25% decrease in TF1-9 by 85% coverage. Among EUs that had previously met the elimination target, results were inconclusive.
Conclusions: Our results support Sustainable Development Goal 6 and provide insight into potential WaSH-related coverage targets for trachoma elimination. Targets can be tested in future trials to improve evidence-based WaSH guidance for trachoma.
Severity of Trachomatous Scarring among Adults in Trachoma-Endemic Amhara Region of Ethiopia.
Bromfield J, Aguwa U, Sata E, Jensen K, Mihretu F, Callahan E Am J Trop Med Hyg. 2024; 111(3_Suppl):121-126.
PMID: 38917786 PMC: 11376122. DOI: 10.4269/ajtmh.23-0894.
Tropical Data: Approach and Methodology as Applied to Trachoma Prevalence Surveys.
Harding-Esch E, Burgert-Brucker C, Jimenez C, Bakhtiari A, Willis R, Bejiga M Ophthalmic Epidemiol. 2023; 30(6):544-560.
PMID: 38085791 PMC: 10751062. DOI: 10.1080/09286586.2023.2249546.
Atekem K, Harding-Esch E, Martin D, Downs P, Palmer S, Kabore A Int Health. 2023; 15(Supplement_2):ii3-ii11.
PMID: 38048384 PMC: 10695457. DOI: 10.1093/inthealth/ihad069.
Potential mitigating role of ivermectin on the spread of Chlamydia trachomatis by Musca sorbens.
Selby R, Jeyam A, Tate A, Kebede F, Downs P PLoS Negl Trop Dis. 2023; 17(10):e0011662.
PMID: 37883529 PMC: 10602231. DOI: 10.1371/journal.pntd.0011662.